JSRAX
Price
$15.92
Change
-$0.10 (-0.62%)
Updated
Jun 13 closing price
Net Assets
2.11B
MLLCX
Price
$12.29
Change
-$0.06 (-0.49%)
Updated
Jun 13 closing price
Net Assets
546.08M
Interact to see
Advertisement

JSRAX vs MLLCX

Header iconJSRAX vs MLLCX Comparison
Open Charts JSRAX vs MLLCXBanner chart's image
JPMorgan SmartRetirement® Income A
Price$15.92
Change-$0.10 (-0.62%)
VolumeN/A
Net Assets2.11B
MFS Lifetime Income C
Price$12.29
Change-$0.06 (-0.49%)
VolumeN/A
Net Assets546.08M
JSRAX vs MLLCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JSRAX vs. MLLCX commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JSRAX is a Hold and MLLCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JSRAX has more cash in the bank: 2.11B vs. MLLCX (546M). JSRAX pays higher dividends than MLLCX: JSRAX (3.55) vs MLLCX (2.77). JSRAX was incepted earlier than MLLCX: JSRAX (19 years) vs MLLCX (20 years). MLLCX (1.63) is less costly to investors than JSRAX (0.90). JSRAX is a more actively managed with annual turnover of: 19.00 vs. MLLCX (9.00). JSRAX has a lower initial minimum investment than MLLCX: JSRAX (500) vs MLLCX (1000). JSRAX annual gain was more profitable for investors over the last year : 6.96 vs. MLLCX (2.63). JSRAX return over 5 years is better than : 12.05 vs. MLLCX (8.80).
JSRAXMLLCXJSRAX / MLLCX
Total Expense Ratio0.691.4548%
Annual Report Gross Expense Ratio0.901.6355%
Fund Existence19 years20 years-
Gain YTD4.0522.933138%
Front Load5%N/A-
Min. Initial Investment500100050%
Min. Initial Investment IRAN/AN/A-
Net Assets2.11B546M386%
Annual Yield % from dividends3.552.77128%
Returns for 1 year6.962.63265%
Returns for 3 years23.7911.42208%
Returns for 5 years12.058.80137%
Returns for 10 years13.7420.5967%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BNTC16.480.56
+3.52%
Benitec Biopharma
TTE63.480.41
+0.65%
TotalEnergies SE
FCN161.25-1.07
-0.66%
FTI Consulting
HYPR0.72-0.02
-2.59%
Hyperfine
CODI6.00-0.35
-5.51%
Compass Diversified